Full text is available at the source.
PD1+ Tumor Associated Macrophages Predict Poor Prognosis of Locally Advanced Esophageal Squamous Cell Carcinoma
Immune cells with PD1 in esophageal cancer linked to worse outcomes
AI simplified
Abstract
CD68PD1 macrophages increased approximately 4.2 times in cancer tissues compared to para-cancer tissues.
- CD68PD1 macrophages express higher levels of M2 markers in esophageal squamous cell carcinoma (ESCC).
- These macrophages are significantly associated with more aggressive cancer traits and poorer patient outcomes.
- Treatment with PD1 can enhance the ability of macrophages to engulf cancer cells and promote a shift towards a more aggressive M1-like phenotype.
- Overall, CD68PD1 macrophages may serve as a prognostic indicator for ESCC.
AI simplified